Biolidics Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SGD 1.32 million compared to SGD 2.49 million a year ago. Net loss was SGD 2.49 million compared to SGD 9.37 million a year ago.

Basic loss per share from continuing operations was SGD 0.0042 compared to SGD 0.0333 a year ago. Diluted loss per share from continuing operations was SGD 0.0042 compared to SGD 0.0333 a year ago.